Endometrial cancer

BMJ

Volumn 343, Issue 7814, 2011, Pages

  Saso, Srdjan ^a   Chatterjee, Jayanta ^a   Georgiou, Ektoras ^a   Ditri, Anthony M ^b   Smith, J Richard ^c   Ghaem Maghami, Sadaf ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Carshalton   (United Kingdom)

^c QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

ABDOMINAL RADIOGRAPHY; ANOVULATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CLIMACTERIUM; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HISTOLOGY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYSTEROSCOPY; MEDICAL HISTORY; MENSTRUAL IRREGULARITY; META ANALYSIS (TOPIC); METASTASIS; METRORRHAGIA; NULLIPARA; OBESITY; OBSERVATIONAL STUDY; OBSTETRIC HEMORRHAGE; ONSET AGE; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PATIENT MONITORING; PATIENT REFERRAL; POSTMENOPAUSE; PRACTICE GUIDELINE; PREMENOPAUSE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY; TREND STUDY; TUMOR BIOPSY; TUMOR CLASSIFICATION; EARLY DIAGNOSIS; ENDOMETRIUM TUMOR; METHODOLOGY; TREATMENT OUTCOME; UTERUS CANCER;

EARLY DETECTION OF CANCER; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM STAGING; REFERRAL AND CONSULTATION; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 79960080439     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d3954     Document Type: Review

References (35)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25. (Pubitemid 43380597)
2. Office for National Statistics. Cancer registration statistics England 2007. 2009. www.statistics.gov.uk/StatBase/Product.asp?vlnk=7720.
3. Kosary CL. Cancer of the corpus uteri. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. NIH Pub No 07-6215 ed. National Cancer Institute, SEER Program, 2007.
4. Cancer Research UK. Uterine (womb) cancer statistics - UK. http://info.cancerresearchuk.org/cancerstats/types/uterus.
5. Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005;14:1132-42. (Pubitemid 40656458)
6. Jick SS, Walker AM, Jick H. Estrogens, progesterone, and endometrial cancer. Epidemiology 1993;4:20-4. (Pubitemid 23070112)
7. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491-505. (Pubitemid 41111699)
8. Mills AM, Longacre TA. Endometrial hyperplasia. Semin Diagn Pathol 2010;27:199-214.
9. Kitchener HC. Chapter 57: cancer of the uterine corpus. In: Edmonds DK, ed. Dewhurst's textbook of obstetrics and gynaecology. 7th ed. Blackwell Publishing, 2007.
10. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. 2005. www.nice.org.uk/nicemedia/pdf/ cg027niceguideline.pdf.
11. Baekelandt MM, Castiglione M, ESMO Guidelines Working Group. Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;4:29-31.
12. Emons G, Kimmig R. Uterus commission of the gynecological oncology working group (AGO). Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma. J Cancer Res Clin Oncol 2009;135:1387-91.
13. Butler J, Kehoe S, Shepherd J, Barton D, Bridges J, Ind T, et al. Referrals to secondary care: Referral rates for postmenopausal bleeding are not respectable. BMJ 2010;341:c7407.
14. Gull B, Karlsson B, Milsom I, Granberg S. Can ultrasound replace dilatation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 2003;188:401-8. (Pubitemid 36253637)
15. Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510-7. (Pubitemid 28507404)
16. Gupta JK, Chien PF, Voit D, Clark TJ, Khan TS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002;81:799-816. (Pubitemid 35026055)
17. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002;109:313-21. (Pubitemid 37329306)
18. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1610-21.
19. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-8. (Pubitemid 29410973)
20. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95:S105-43.
21. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009;105:109.
22. Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, Leitao MM Jr, Chi DS, et al. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer 2011;21:511-6.
23. Lin F, Zhang QJ, Zheng FY, Zhao HQ, Zeng QQ, Zheng MH, et al. Laparoscopically assisted versus open surgery for endometrial cancer - a meta-analysis of randomized controlled trials. Int J Gynecol Cancer 2008;18:1315-25.
24. de la Orden SG, Reza MM, Blasco JA, Andradas E, Callejo D, Perez T. Laparoscopic hysterectomy in the treatment of endometrial cancer: a systematic review. J Minim Invasive Gynecol 2008;15:395-401. (Pubitemid 351888966)
25. Ju W, Myung SK, Kim Y, Choi HJ, Kim SC, Korean Meta-Analysis Study Group. Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 2009;19:400-6.
26. Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 2010;375:816-23.
27. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987;60:2035-41. (Pubitemid 17145924)
28. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010;20:CD007585.
29. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-16.
30. ASTEC study group. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
31. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007;106:282-8. (Pubitemid 47096660)
32. Lambrou NC, Gomez-Marin O, Mirhashemi R, Beach H, Salom E, Almeida-Parra Z, et al. Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol Oncol 2004;93:653-8. (Pubitemid 38766051)
33. Ayhan A, Taskiran C, Celik C, Yuce K, Kucukali T. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int J Gynecol Cancer 2002;12:448-53.
34. Brown AK, Madom L, Moore R, Granai CO, DiSilvestro P. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes. Gynecol Oncol 2007;105:55-8. (Pubitemid 46441439)
35. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009;373:137-46.